Incidence of Autoimmune and Related Disorders After Resolution of Endogenous Cushing Syndrome in Children

Christina Tatsi; Meg Keil; Charalampos Lyssikatos; Elena Belyavskaya; Constantine A. Stratakis; Maya B. Lodish

doi:10.1055/s-0044-101144

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2018; 50(04): 290-295
DOI: 10.1055/s-0044-101144

Endocrine Care

Incidence of Autoimmune and Related Disorders After Resolution of Endogenous Cushing Syndrome in Children

Authors

Christina Tatsi

¹Section on Endocrinology and Genetics, Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland, USA
Meg Keil

¹Section on Endocrinology and Genetics, Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland, USA
Charalampos Lyssikatos

¹Section on Endocrinology and Genetics, Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland, USA
Elena Belyavskaya

¹Section on Endocrinology and Genetics, Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland, USA
Constantine A. Stratakis

¹Section on Endocrinology and Genetics, Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland, USA
Maya B. Lodish

¹Section on Endocrinology and Genetics, Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland, USA

Abstract

Glucocorticoids are widely used for immunosuppression in autoimmune diseases. After the resolution of hypercortisolemia, the immune system recovers allowing for autoimmune diseases to manifest. Here we investigated the presence of autoimmune and related diseases that developed after cure of endogenous Cushing syndrome (CS) in children. We identified 129 children who were diagnosed and successfully treated for endogenous CS at the National Institutes of Health from 1997 until 2017, and who were followed for at least 6 months after treatment. We performed a retrospective chart review analysis to identify the presence of autoimmune or related diseases after cure. Ten children were diagnosed with a new autoimmune or related disorder after resolution of hypercortisolemia. This results in a frequency of 7.8% of our pediatric CS population. The identified patients had a shorter duration of hypercortisolemia prior to diagnosis, but did not otherwise differ from the remaining patients. The various identified diseases were: celiac disease (n=1), psoriasis (n=1), Hashimoto thyroiditis (n=1), Graves disease (n=1), optic neuritis (n=2), skin hypopigmented lesions/vitiligo (n=2), allergic rhinitis/asthma (n=1), and neuropathy responding to glucocorticoid treatment (n=1). The reported time between the treatment of CS and diagnosis of autoimmune disorder ranged from 6 to 19 months. The presence of autoimmune or related diseases might be masked by the hypercortisolemic state in endogenous CS. After resolution of hypercortisolemia, the presentation of new autoimmune diseases or recurrence of previously known autoimmune conditions should be considered when concerning symptoms arise.

Key words

hypercortisolemia - immune system - thyroiditis - children

Full Text

References

References
1 Pufall MA.. Glucocorticoids and Cancer. Adv Exp Med Biol 2015; 872: 315-333
2 Oppong E, Cato AC. Effects of Glucocorticoids in the Immune System. Adv Exp Med Biol 2015; 872: 217-233
3 Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F. Glucocorticoids. Best Pract Res Clin Rheumatol 2011; 25: 891-900
4 Sarlis NJ, Chanock SJ, Nieman LK. Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab 2000; 85: 42-47
5 Busillo JM, Cidlowski JA. The five Rs of glucocorticoid action during inflammation: Ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab 2013; 24: 109-119
6 Colao A, Pivonello R, Faggiano A, Filippella M, Ferone D, Di Somma C, Cerbone G, Marzullo P, Fenzi G, Lombardi G. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol (Oxf) 2000; 53: 13-19
7 da Mota F, Murray C, Ezzat S. Overt immune dysfunction after Cushing's syndrome remission: A consecutive case series and review of the literature. J Clin Endocrinol Metab 2011; 96: E1670-E1674
8 Stratakis CA, Mastorakos G, Magiakou MA, Papavasiliou E, Oldfield EH, Chrousos GP. Thyroid function in children with Cushing's disease before and after transsphenoidal surgery. J Pediatr 1997; 131: 905-909
9 Kiehna EN, Keil M, Lodish M, Stratakis C, Oldfield EH. Pseudotumor cerebri after surgical remission of Cushing's disease. J Clin Endocrinol Metab 2010; 95: 1528-1532
10 Stratakis CA. Diagnosis and clinical genetics of cushing syndrome in pediatrics. Endocrinol Metab Clin North Am 2016; 45: 311-328
11 Yakushiji F, Kita M, Hiroi N, Ueshiba H, Monma I, Miyachi Y. Exacerbation of rheumatoid arthritis after removal of adrenal adenoma in Cushing's syndrome. Endocr J 1995; 42: 219-223
12 Noguchi Y, Tamai H, Fujisawa K, Nagano J, Mukuta T, Komaki G, Masubayashi S, Kubo C, Torisu M, Nakagaki H, Imayama S. Systemic lupus erythematosus after pituitary adenomectomy in a patient with Cushing's disease. Clin Endocrinol (Oxf) 1998; 48: 670-672
13 Candrina R, Di Stefano O. Exacerbation of celiac disease after cure of Cushing's disease. Am J Med 1993; 95: 341
14 Herold MJ, McPherson KG, Reichardt HM. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 2006; 63: 60-72
15 Flammer JR, Rogatsky I. Minireview: Glucocorticoids in autoimmunity: Unexpected targets and mechanisms. Mol Endocrinol 2011; 25: 1075-1086
16 Saffar AS, Ashdown H, Gounni AS. The molecular mechanisms of glucocorticoids-mediated neutrophil survival. Curr Drug Targets 2011; 12: 556-562
17 Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995; 154: 4719-4725
18 Mussig K, Gallwitz B. Haring HU, Seif FJ. Manifestation of thyroid autoimmunity in patients successfully treated for hypercortisolism. Clin Endocrinol (Oxf) 2004; 61: 284
19 Kasperlik-Zatuska AA, Zgliczynski W. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol (Oxf) 2001; 54: 411 author's reply 411
20 Liu Y, Li C, Zhao W, Wang Y. Hashimoto's thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults. Horm Metab Res 2017; 49: 732-738
21 Veit F, Graf D, Momberger S, Helmich-Kapp B, Ruschenburg I, Peters A, Kussmann J, Saeger W, Schmidt KW, Toetsch M, Nestler K, Mann K. Papillary thyroid cancer and coexisting autoimmune thyroiditis. Horm Metab Res 2017; 49: 869-872
22 Olnes MJ, Kotliarov Y, Biancotto A, Cheung F, Chen J, Shi R, Zhou H, Wang E, Tsang JS, Nussenblatt R. Consortium CHI . Effects of systemically administered hydrocortisone on the human immunome. Sci Rep 2016; 6: 23002
23 Choung RS, Unalp-Arida A, Ruhl CE, Brantner TL, Everhart JE, Murray JA. Less hidden celiac disease but increased gluten avoidance without a diagnosis in the united states: Findings from the national health and nutrition examination surveys from 2009 to 2014. Mayo Clin Proc 2016 pii: S0025-6196(16)30634-6. doi: 10.1016/j.mayocp.2016.10.012, Dec 5 [Epub ahead of print]
24 Roberts G, Xatzipsalti M, Borrego LM, Custovic A, Halken S, Hellings PW, Papadopoulos NG, Rotiroti G, Scadding G, Timmermans F, Valovirta E. Paediatric rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy 2013; 68: 1102-1116
25 Milligan KL, Matsui E, Sharma H. Asthma in urban children: Epidemiology, environmental risk factors, and the public health domain. Curr Allergy Asthma Rep 2016; 16: 33
26 Relvas M, Torres T. Pediatric Psoriasis. Am J Clin Dermatol 2017; 18: 797-811
27 Phiske MM. Vitiligo in Children: A Birds Eye View. Curr Pediatr Rev 2016; 12: 55-66
28 Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: A review. JAMA Pediatr 2016; 170: 1008-1019
29 Yeh EA, Graves JS, Benson LA, Wassmer E, Waldman A. Pediatric optic neuritis. Neurology 2016; 87: S53-S58